CH452513A - Verfahren zur Herstellung von 1,5-Bisdehydrosteroiden - Google Patents
Verfahren zur Herstellung von 1,5-BisdehydrosteroidenInfo
- Publication number
- CH452513A CH452513A CH5764A CH5764A CH452513A CH 452513 A CH452513 A CH 452513A CH 5764 A CH5764 A CH 5764A CH 5764 A CH5764 A CH 5764A CH 452513 A CH452513 A CH 452513A
- Authority
- CH
- Switzerland
- Prior art keywords
- bisdehydrosteroids
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- A63F1/00—Card games
- A63F1/06—Card games appurtenances
- A63F1/18—Score computers; Miscellaneous indicators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Multimedia (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US251747A US3127430A (en) | 1963-01-16 | 1963-01-16 | 17alpha-methyl-1, 5-androstadienes-17beta-ol-3-one and derivatives thereof |
US251744A US3127428A (en) | 1963-01-16 | 1963-01-16 | Process for converting a 3-keto-delta-steroid to the corresponding 3-keto delta-compound |
US263441A US3332967A (en) | 1963-01-16 | 1963-03-07 | 3-hydroxy-1, 5-bis-dehydro steroids and methods for their manufacture |
US31227363A | 1963-09-30 | 1963-09-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH452513A true CH452513A (de) | 1968-03-15 |
Family
ID=27500405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH5764A CH452513A (de) | 1963-01-16 | 1964-01-07 | Verfahren zur Herstellung von 1,5-Bisdehydrosteroiden |
Country Status (4)
Country | Link |
---|---|
CH (1) | CH452513A (da) |
DE (1) | DE1493146A1 (da) |
DK (1) | DK114971B (da) |
SE (1) | SE314366B (da) |
-
1964
- 1964-01-07 CH CH5764A patent/CH452513A/de unknown
- 1964-01-14 DE DE19641493146 patent/DE1493146A1/de active Pending
- 1964-01-15 SE SE46864A patent/SE314366B/xx unknown
- 1964-01-15 DK DK20464A patent/DK114971B/da unknown
Also Published As
Publication number | Publication date |
---|---|
DE1493146A1 (de) | 1969-08-07 |
SE314366B (da) | 1969-09-08 |
DK114971B (da) | 1969-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH468966A (de) | Verfahren zur Herstellung von 3-Aminotricyclo-(4,3,1,1,3,8)-undecan | |
CH459196A (de) | Verfahren zur Herstellung von 4,6-Pregnadienderivaten | |
CH437316A (de) | Verfahren zur Herstellung von substituierten Phenyl-amino-1,3-diazacyclopenten-(2)-Verbindungen | |
CH458587A (de) | Verfahren zur Herstellung von 8,9,10,11-Tetrahydro-12-phthaloperinon | |
CH479574A (de) | Verfahren zur Herstellung von 13-Jod-14-oxo 13,14-seco-steroiden | |
CH460766A (de) | Verfahren zur Herstellung von 3,3-Alkyliden-19-nor-steroiden | |
CH436317A (de) | Verfahren zur Herstellung von 5-Joduracil-2'-desoxyribosid-3',5'-di-Estern | |
CH449610A (de) | Verfahren zur Herstellung von Oestra-4,9-dien-3-olen | |
AT247866B (de) | Verfahren zur Herstellung von 2, 6-Dichlorbenzonitril | |
CH446312A (de) | Verfahren zur Herstellung von cis,cis-Cyclodecadien-(1,6) | |
AT244334B (de) | Verfahren zur Herstellung von neuen 2, 1-Benzisothiazolen | |
CH437320A (de) | Verfahren zur Herstellung von 4-Amino-5-hydroxypyridazonen (6) | |
CH451163A (de) | Verfahren zur Herstellung von 2,2-Bipyridylium-dihalogeniden | |
CH445477A (de) | Verfahren zur Herstellung von 1-Hydroxy-2,2,6,6-tetrachlorcyclohexankarbonamid-1 | |
CH441352A (de) | Verfahren zur Herstellung von 1-Phenyl-3-butyl-4-methyl-triazolon-(5) | |
CH459242A (de) | Verfahren zur Herstellung von 1,2-Dihydro-1-hydroxy-1,3,5-triazinen | |
AT247848B (de) | Verfahren zur Herstellung von 1, 3-Dioxo-2-alkylcyclopentanen | |
CH441583A (de) | Verfahren zur Herstellung von 1,4-Diarylamino-5-nitro-8-hydroxy-anthrachinonen | |
CH439328A (de) | Verfahren zur Herstellung von 3,5-Dijodthyroninen | |
CH435245A (de) | Verfahren zur Herstellung von 1-Aryl-perchlor-2-aza-alkenen-(2) | |
CH427830A (de) | Verfahren zur Herstellung von substituierten 1,4-Benzodiazepinen | |
CH444154A (de) | Verfahren zur Herstellung von 1(10),2,4a(5)-A-Homoöstratrien-4-onderivaten | |
AT253703B (de) | Verfahren zur Herstellung von 3, 6-Dioxo-A-nor-B-homo-steroiden | |
CH471056A (de) | Verfahren zur Herstellung von 2,5-Dialkoxybenzaldehyden | |
CH451151A (de) | Verfahren zur Herstellung von 1,4-Benzoxazin-2-onen |